Viela Bio to Webcast First Quarter 2020 Financial Results and Program Highlights on May 13, 2020
Viela Bio (Nasdaq: VIE) will host a webcast and conference call on May 13, 2020, at 5:00 p.m. ET to discuss its first quarter 2020 financial results and program highlights.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Viela Bio (Nasdaq: VIE) will host a webcast and conference call on May 13, 2020, at 5:00 p.m. ET to discuss its first quarter 2020 financial results and program highlights. The call will be accessible domestically at (877) 783-8848 or internationally at (631) 350-0960 using conference ID #: 3052446. The archived webcast will be available for replay approximately two hours after the event on the company's website. Viela Bio focuses on developing innovative treatments for autoimmune and severe inflammatory diseases.
Positive
- Upcoming conference call to discuss Q1 2020 financial results and program highlights may bolster investor confidence.
Negative
- None.
Details
News Market Reaction – VIE
The recorded move for VIE in the trading session of this news was -6.96%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., May 06, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today announced it will host a webcast and conference call on Wednesday, May 13, 2020 at 5:00 p.m. ET to discuss its first quarter 2020 financial results and program highlights.
The webcast will be accessible on the Events & Presentations page of the Company’s website. Individuals can participate in the conference call by dialing (877) 783-8848 (domestic) or (631) 350-0960 (international) and referring to conference ID #: 3052446. The archived webcast will be available for replay on the Viela Bio website approximately two hours after the event.
About Viela Bio
Viela Bio, headquartered in Gaithersburg, Maryland, is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases. For more information, please visit www.vielabio.com.
Source: Viela Bio
Contacts:
Investors:
Solebury Trout
Chad Rubin
646-378-2947
crubin@soleburytrout.com
Media:
Solebury Trout
Amy Bonanno
914-450-0349
abonanno@soleburytrout.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.